9-130458549-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_054012.4(ASS1):c.323G>T(p.Arg108Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00207 in 1,613,360 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R108W) has been classified as Likely benign.
Frequency
Consequence
NM_054012.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.323G>T | p.Arg108Leu | missense_variant | 4/15 | ENST00000352480.10 | |
ASS1 | NM_000050.4 | c.323G>T | p.Arg108Leu | missense_variant | 5/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.323G>T | p.Arg108Leu | missense_variant | 4/15 | 1 | NM_054012.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00556 AC: 847AN: 152228Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00295 AC: 736AN: 249624Hom.: 7 AF XY: 0.00246 AC XY: 333AN XY: 135330
GnomAD4 exome AF: 0.00170 AC: 2480AN: 1461014Hom.: 19 Cov.: 32 AF XY: 0.00169 AC XY: 1226AN XY: 726802
GnomAD4 genome ? AF: 0.00562 AC: 856AN: 152346Hom.: 4 Cov.: 33 AF XY: 0.00534 AC XY: 398AN XY: 74506
ClinVar
Submissions by phenotype
Citrullinemia type I Pathogenic:1Uncertain:2Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | May 09, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2002 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 18, 2022 | Variant summary: ASS1 c.323G>T (p.Arg108Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0038 in 394424 control chromosomes, including 11 homozygotes (gnomAD v2.1 and v3.1 non-v2 datasets). The variant was reported predominantly within the African or African-American subpopulation at a frequency of 0.014 (including 7 homozygotes), the observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3.4-fold of the estimated maximal expected allele frequency for a pathogenic variant in ASS1 causing Citrullinemia Type I phenotype (0.0041), strongly suggesting that the variant is a benign polymorphism. Though the variant, c.323G>T, has been reported in the literature in individuals affected with Citrullinemia Type I (Vilaseca_2001, Haberle_2002, Tabor_2014,), these reports do not provide unequivocal conclusions about association of the variant with Citrullinemia Type I. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven other submitters have provided clinical-significance assessments for this variant in ClinVar after 2014 without evidence for independent evaluation, and classified the variant as VUS (n=2), likely benign (n=3) / benign (n=2). Based on the evidence outlined above, the variant was classified as benign. - |
Citrullinemia Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 02, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | ASS1: BS1, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at